Suicide: A focus on primary care

Wisconsin Medical Journal

Volumn 103, Issue 6, 2004, Pages 88-92

  Gillmore, John M ^a   Chan, Carlyle H ^b  

^a Veterans Administration   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VENLAFAXINE;

ADOLESCENT; CHILD; DECISION MAKING; EPIDEMIOLOGICAL DATA; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; PRIMARY MEDICAL CARE; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SUICIDAL BEHAVIOR; SUICIDE; DEPRESSION; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; PRIMARY HEALTH CARE; RISK FACTORS; SUICIDE;

EID: 16644402766     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Narrow WE, Regier DA, Rae DS, et al. Use of services by person with mental and addictive disorders: findings from the National Institute of Mental Health Epidemiologic Catchment Are Program. Arch Gen Psych. 1993;50:95-107.
2. National Institute of Mental Health. Suicide facts. Available at www.nimh.nih.gov/SuicidePrevention/suifact.cfm. Accessed October 9, 2004.
3. Anderson RN, Kochanek KD, Murphy SL. Report of Final Mortality Statistics, 1995. Monthly Vital Statistics Report. Hyattsville, Md.: National Center for Health Statistics; 1997:45(suppl2).
4. Psychiatric Emergencies. In: Sadock BJ, Sadock VA, eds. Kaplan & Sadock's Synopsis of Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003:913-922.
5. National Vital Statistics Reports 50(15). Hyattsville, MD. National Center for Health Statistics. DHHS Publication No. (PHS) 2002-1120.
6. Satcher D. The Surgeon General's call to action to prevent suicide. Department of Health and Human Services, US Public Health Service, 1999.
7. Centers for Disease Control and Prevention (CDC). Methods of suicide among persons aged 10-19 years-United States, 1992-2001. MMWR Morb Mortal Wkly Rep. 2004;53(22):471-474.
8. Perlis RH, Stern TA. Suicide. In: Stern TA, Herman JB, eds. Massachusetts General Hospital Psychiatry Update and Board Preparation. 2nd ed. New York: McGraw Hill; 2004:405-409.
9. King KA. Fifteen prevalent myths concerning adolescent suicide. J Sch Health. 1999;69(4):159-161.
10. Pokorny AD. Prediction of suicide in psychiatric pts. Arch Gen Psych. 1983;40:249-257.
11. Moscicki EK. Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am. 1997;20:499-517.
12. Muzina DJ. What physicians can do to prevent suicide. Cleve Clin J Med. 2004;71(3):242-250.
13. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60(suppl 2):57-62; discussion 75-76, 113-116.
14. Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry. 1998;172:35-37.
15. O'Leary D, Paykel E, Todd C, Vardulaki K. Suicide in primary affective disorders revisited: a systematic review by treatment era. J Clin Psychiatry. 2001;62(10):804-811.
16. Simpson SG, Jamison KR. The risk of suicide in patients with bipolar disorders. J Clin Psychiatry. 1999;60(suppl 2):53-56; discussion 75-76, 113-116.
17. Lepine JP, Chignon JM, Teherani M. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry. 1993;50:144-149.
18. Marzuk PM. Suicidal behavior and HIV illnesses. Int Rev Psychiatry. 1991;3:365-371.
19. McGuffin P, Marusic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis. 2001;22(2):61-65.
20. Hansen, L. A critical review of akathisia, and its possible association with suicidal behaviour. Hum Psychopharmacol. 2001;16(7):495-505.
21. FDA Talk Paper: FDA Issues Public Health Advisory on Cautions for Use of Antidepressants in Adults and Children. March 22, 2004.
22. FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committees. September 16, 2004.
23. Important drug warning: Until further information is available, Paxil® (paroxetine hydrochloride) should not be used in children and adolescents under 18 years of age [Dear Health Care Professional Letter]. Mississauga (ON): GlaxoSmithKline Inc.; July 2003.
24. Holden, C. FDA weighs suicide risk in children on antidepressants. Science. 2004;303(5659):745.
25. Preliminary Report of the Task Force on SSRIs and Suicidal Behavior in Youth. American College of Neuropsychopharmacology. Jan 21, 2004.
26. Beasley CM Jr, Dornseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ. 1991;303(6809):1058-1059.
27. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160(4):790-792.
28. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry. 1999;60(suppl 2):77-84; discussion 111-116.
29. Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry. 2003;64(suppl 5):44-52.
30. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand. 2001;104(3):163-172.
31. Nilsson A. Lithium therapy and suicide risk. J Clin Psychiatry. 1999;60(suppl 2):85-88; discussion 111-116.
32. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290(11):1467-1473.
33. Meltzer HY, Alphs L, Green AI, et al, and the International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). [published correction appears in Arch Gen Psychiatry. 2003;60(7):735]. Arch Gen Psychiatry. 2003;60(1):82-91.
34. Meltzer HY, Alphs L, Green AI, et al, and the International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). [published correction appears in Arch Gen Psychiatry. 2003;60(7):735]. Arch Gen Psychiatry. 2003;60(1):82-91.